YD Bio (NASDAQ:YDES) Trading 7.9% Higher – What’s Next?

Shares of YD Bio Limited (NASDAQ:YDES) rose 7.9% on Monday . The company traded as high as $7.50 and last traded at $7.8770. Approximately 759 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 37,850 shares. The stock had previously closed at $7.30.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Weiss Ratings reissued a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. Wall Street Zen raised YD Bio from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, YD Bio presently has a consensus rating of “Sell”.

YD Bio Stock Performance

The business’s 50 day moving average is $10.07.

Institutional Inflows and Outflows

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC increased its position in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 58,363 shares of the biotechnology company’s stock after acquiring an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent reporting period.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.